Meloxicam Mega Study
Contents
Meloxicam
Meloxicam

Related

A
Tablets
A
Treatments
A
Effects
A
User Variables 5
A
Measurements 13

Tags

Meloxicam

Treatment Effectiveness

User reported effectiveness ratings Meloxicam for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Back Pain 50% 50% 0% 0% 0% 2
Hip Pain 0% 50% 0% 50% 0% 2
Palindromic Rheumatism 0% 0% 0% 0% 100% 1

Below is the degree of change seen after Meloxicam is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Meloxicam Info

Property Value
Variable Name Meloxicam
Aggregation Method SUM
Analysis Performed At 2020-10-11
Duration of Action 21 days
Filling Value 0
Kurtosis 2.6309523809524
Maximum Allowed Value 20 tablets
Mean 0.305555 tablets
Median 0.25 tablets
Minimum Allowed Value 0 tablets
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 26
Number of Measurements 13
Number of Measurements (including those generated by tagged, joined, or child variables) 13
Public true
Onset Delay 30 minutes
Standard Deviation 0.10694815798662
Unit Tablets
User Variables 5
UPC 035127699370
Variable Category Treatments
Variable ID 1371
Variance 0.045751633986928